Broadening horizons: the contribution of mitochondria-associated endoplasmic reticulum membrane (MAM) dysfunction in diabetic kidney disease

Area of Science:

• Cell Biology
• Nephrology
• Metabolic Diseases

Background:

• Diabetic kidney disease (DKD) is a major global health concern with complex causes and few treatments.
• Mitochondrial and endoplasmic reticulum (ER) dysfunction are key contributors to DKD pathogenesis.
• Mitochondria-associated ER membrane (MAM) is a critical interface connecting ER and mitochondria, vital for cellular functions.

Purpose of the Study:

• To comprehensively review the physiological roles of MAMs.
• To elucidate the impact of MAMs on DKD progression.
• To discuss therapeutic strategies targeting MAMs for DKD treatment.

Main Methods:

• Literature review of existing studies on MAMs and DKD.
• Analysis of MAM's role in cellular processes relevant to DKD.
• Exploration of current and future pharmaceutical research targeting MAMs.

Main Results:

• MAM regulates key pathways in DKD, including glucose/lipid metabolism, inflammation, ER stress, mitochondrial dynamics, and autophagy.
• Dysfunction of MAM significantly contributes to the development and progression of DKD.
• Targeting MAM resident proteins shows potential for novel DKD therapies.

Conclusions:

• MAM plays a pivotal role in DKD pathogenesis through its regulation of cellular homeostasis.
• Pharmaceutical targeting of MAM offers a promising avenue for developing precise therapies for DKD.
• Further research into MAM's role in DKD can provide new insights for clinical treatment.